Genecopoeia, Inc.

Rockville, MD

UEI
CELJZYQU3MK7
CAGE
4DY49
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Minority Owned Business
  • Asian-Pacific American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
9620 Medical Center Dr #101, Rockville, MD 20850, USA
Website
genecopoeia.com
Founded
2000
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Genecopoeia, Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
GC-K3038-CF gateway plus shuttle clone for STAT4(NM_001243835.2) [without stop codon] (purifi ED plasmid) Contract · 75N92E24P00271 National Human Genome Research Institute $13,349
Genecopoeia INC:1108508 [24-003018] Contract · 75N92B24P00091 National Insititue of Arthritis and Musculoskeletal and Skin Diseases $22,320
Antibody autoimmune research study Contract · 36C24723P1248 Veterans Integrated Service Network 7 $14,520
Human serum sample Contract · 36C24723P0658 Veterans Integrated Service Network 7 $17,450
Lentiviral preceiver LV233 clone expressionquantity of 14 @ $561.00SHIPPING $30.00 Contract · HHSN272201800429P National Institute of Allergy and Infectious Diseases $8,013

About Genecopoeia, Inc.

Genecopoeia, Inc. is a minority-owned, Asian-Pacific American-owned for-profit corporate entity registered in SAM.gov since 2006, specializing in biotechnology and scientific research products. The company appears to be a manufacturer of goods focused on genetic research materials, plasmid development, and biological sample services. Its current SAM.gov registration remains active through May 9, 2025, indicating ongoing eligibility to receive federal contracts and grants.

Over the past year, Genecopoeia, Inc. has secured multiple federal contract awards from civilian agencies, primarily in the biomedical research sector. The company has been awarded purchase order contracts from the National Human Genome Research Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases, and Veterans Integrated Service Network 7. These contracts, ranging in value from $13,349 to $22,320, have involved specialized scientific services such as providing Gateway Plus Shuttle Clone plasmids, conducting antibody autoimmune research studies, and delivering human serum samples. Each contract has been awarded as a firm fixed-price purchase order without specific set-aside designations. The contracts demonstrate Genecopoeia's capabilities in supporting federal research initiatives across different healthcare and genomic research domains, with a particular focus on detailed scientific product manufacturing and research support services.

SBA capabilities narrative

GeneCopoeia, Inc. is a US-based manufacturer and provider of genomics and proteomics products and services for academic and governmental research institutes, pharmaceutical and biotechnology industry.

Quick answers

What is Genecopoeia, Inc.'s UEI?

Genecopoeia, Inc.'s Unique Entity ID (UEI) in SAM.gov is CELJZYQU3MK7.

What is Genecopoeia, Inc.'s CAGE code?

Genecopoeia, Inc.'s CAGE code is 4DY49.

What is Genecopoeia, Inc.'s primary NAICS code?

Genecopoeia, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Genecopoeia, Inc. located?

Genecopoeia, Inc.'s physical address in SAM.gov is 9620 Medical Center Dr #101, Rockville, MD 20850, USA.

Is Genecopoeia, Inc. registered in SAM.gov?

Yes. Genecopoeia, Inc.'s SAM.gov registration is active through September 17, 2027.

What is Genecopoeia, Inc.'s most recent federal award?

Genecopoeia, Inc.'s most recent federal contract award is GC-K3038-CF gateway plus shuttle clone for STAT4(NM_001243835.2) [without stop codon] (purifi ED plasmid) (75N92E24P00271), from National Human Genome Research Institute, on August 22, 2024.

On GovTribe

See Genecopoeia, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors